Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2004.033977v1, 2004; 10.1373/clinchem.2004.033977
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.033977v1
50/10/1809    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, C.
Right arrow Articles by Lackner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, C.
Right arrow Articles by Lackner, K. J.

Received on March 12, 2004
Accepted on June 28, 2004

Clinical Immunology

Kappa Free Light Chains in Cerebrospinal Fluid as Markers of Intrathecal Immunoglobulin Synthesis

Christian Fischer 1, Borros Arneth 1, Jürgen Koehler 2, Johannes Lotz 1, Karl J. Lackner 1*

1 Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University, Mainz, Germany
2 Department of Neurology, Johannes Gutenberg University, Mainz, Germany

* To whom correspondence should be addressed. E-mail: lackner{at}zentrallabor.klinik.uni-mainz.de.

Background: Intrathecal immunoglobulin synthesis is observed in several inflammatory disorders of the central nervous system, but its detection by current laboratory tests is either tedious or relatively insensitive. We assessed the diagnostic accuracy of an assay for {kappa} free light chains ({kappa}FLC) in cerebrospinal fluid (CSF) and serum, and compared it with traditional tests for intrathecal immunoglobulin synthesis.

Methods: {kappa}FLCs were measured by nephelometry in CSF/serum pairs from 112 patients. Samples were excluded if artificial blood contamination of CSF (n = 12) or monoclonal bands in both CSF and serum (n = 5) were present. The remaining sample pairs were grouped according to the presence (n = 71) or absence (n = 24) of oligoclonal bands. Data were analyzed as {kappa}FLC concentrations in CSF, as {kappa}FLC CSF/serum ratios, and by use of the quotient diagram described previously for immunoglobulins.

Results: Both {kappa}FLC concentrations in CSF and the {kappa}FLC CSF/serum ratio identified patients with oligoclonal bands with high specificity and sensitivity. The areas under the ROC curves were 0.991 (95% confidence interval, 0.944-0.998) and 0.978 (0.924-0.996), respectively. Exclusion of patients with impaired blood-CSF barrier function further improved diagnostic accuracy. To account for patients with impaired blood-CSF barrier function, data were also analyzed in a quotient diagram. Only two patients without detectable oligoclonal bands would have been misclassified by this approach.

Conclusions: Our data indicate that the nephelometric assay for {kappa}FLCs in CSF reliably detects intrathecal immunoglobulin synthesis. This automated and quantitative method could simplify the diagnostic procedure for CSF analysis in the routine laboratory.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. R. Bradwell
Serum Free Light Chain Measurements Move to Center Stage
Clin. Chem., May 1, 2005; 51(5): 805 - 807.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. J. Thompson
Quality versus Quantity: Which Is Better for Cerebrospinal Fluid IgG?
Clin. Chem., October 1, 2004; 50(10): 1721 - 1722.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.